1.
|
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Other
Protocol IDs: 4-2010-0368, NCT01234272
|
|
2.
|
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014899, FENPAI2003, JNS020QD-JPN-C02, NCT00644787
|
|
3.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and older
Sponsor: NCI
Protocol IDs: NCCTG-889252, MAYO-889252, NCI-P91-0015
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: C25608/3039/BP/US, NCT00105287
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 099-15, NCT00105937
|
|
6.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EN3267-005, NCT00262678
|
|
7.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EN3267-007, NCT00263575
|
|
8.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FEN-202, NCT00293020
|
|
9.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FEN-201, NCT00293033
|
|
10.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: FT-018-IM, 2005-002348-24, NCT00362583
|
|
11.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPO45/06/FCNS, NCT00458510
|
|
12.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPO43/06/FCNS, NCT00459277
|
|
13.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: FT-019-IM, 2006-002087-26, NCT00496392
|
|
14.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0961, NCT00542542
|
|
15.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014896, JNS020QD-JPN-C01, NCT00641667
|
|
16.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-0702, NCT00684632
|
|
17.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-0703, NCT00683995
|
|
18.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-004, NCT01326689
|
|
19.
|
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NFCP1-2010, NCT01248611
|
|
20.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 3 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: C8278/2022/BP/US-CA, NCT00236093
|
|
21.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: FT-017-IM, 2005-002347-82, NCT00345735
|
|
22.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 3 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: C8278b/202/BP/US-CA, UCLA-0406088-02, CEPHALON-C8278b/202/BP/US-CA, NCT00236041
|
|
23.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2246-0401, NCT00355628
|
|
24.
|
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: YALE-HIC-8358, NCI-V96-0817
|
|
25.
|
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 to 79
Sponsor: Other
Protocol IDs: YALE-HIC-8356, NCI-V96-0818
|
Mobile | Español
